Alnylam Pharmaceuticals
ALNY
#625
Rank
$31.80 B
Marketcap
$246.58
Share price
1.06%
Change (1 day)
32.41%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Market capitalization of Alnylam Pharmaceuticals (ALNY)

Market cap: $31.80 Billion USD

As of December 2024 Alnylam Pharmaceuticals has a market cap of $31.80 Billion USD. This makes Alnylam Pharmaceuticals the world's 625th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Alnylam Pharmaceuticals from 2004 to 2024

End of year Market Cap

Year Marketcap Change
2024$31.80 B32.4%
2023$24.02 B-17.84%
2022$29.23 B44.16%
2021$20.28 B34.32%
2020$15.10 B16.87%
2019$12.92 B75.15%
2018$7.37 B-41.45%
2017$12.59 B292.16%
2016$3.21 B-59.89%
2015$8.01 B6.97%
2014$7.48 B82.71%
2013$4.09 B327.85%
2012$0.95 B175.09%
2011$0.34 B-16.59%
2010$0.41 B-43.36%
2009$0.73 B-28.02%
2008$1.02 B-13.62%
2007$1.18 B49.54%
2006$0.79 B207.77%
2005$0.25 B78.85%
2004$0.14 B

End of Day market cap according to different sources

On Dec 17th, 2024 the market cap of Alnylam Pharmaceuticals was reported to be:

$31.80 Billion USD
by Yahoo Finance info icon info icon
$31.80 Billion USD
by CompaniesMarketCap info icon info icon
$31.80 Billion USD
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
$2.77 B-91.29%๐Ÿ‡บ๐Ÿ‡ธ USA
$81.31 B 155.69%๐Ÿ‡บ๐Ÿ‡ธ USA
$12.01 B-62.23%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.08 B-96.59%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.10 B-99.67%๐Ÿ‡บ๐Ÿ‡ธ USA
$198.38 B 523.76%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$122.70 B 285.80%๐Ÿ‡ซ๐Ÿ‡ท France
$23.65 B-25.61%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel